{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:56:30Z","timestamp":1789588590004,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"State contract in frame of Russian Federal Goal program \u201cDevelopment of pharmaceutical and medical industry of Russian Federation\u201d","award":["GK \u2116 14.N08.11.0003"],"award-info":[{"award-number":["GK \u2116 14.N08.11.0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1884-5","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T10:25:03Z","timestamp":1475835903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Anna S.","family":"Ershova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Gra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Lyaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana M.","family":"Grunina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem P.","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail S.","family":"Bartov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya M.","family":"Savina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Sergienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya M.","family":"Galushkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Gudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov I.","family":"Kozlovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan S.","family":"Kholodilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa V.","family":"Gmyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina G.","family":"Karganova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir G.","family":"Lunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Karyagina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Gintsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"1884_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","volume":"2","author":"J Suss","year":"2010","unstructured":"Suss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asian overview. Ticks Tick Borne Dis. 2010;2:2\u201315.","journal-title":"Ticks Tick Borne Dis"},{"key":"1884_CR2","volume-title":"Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses","author":"AMQ King","year":"2012","unstructured":"King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier; 2012."},{"key":"1884_CR3","first-page":"712","volume-title":"Fields virology","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach BD, Murray CL, Thiel H-J, Rice CM. Flaviviridae. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2013. p. 712\u201346.","edition":"6"},{"key":"1884_CR4","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1016\/j.vaccine.2014.02.046","volume":"32","author":"OV Morozova","year":"2014","unstructured":"Morozova OV, Bakhvalova VN, Potapova OF, Grishechkin AE, Isaeva EI, Aldarov KV, et al. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus. Vaccine. 2014;32:3101\u20136.","journal-title":"Vaccine"},{"key":"1884_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","volume":"59","author":"BD Lindenbach","year":"2003","unstructured":"Lindenbach BD, Rice CM. Molecular biology of flaviviruses. Adv Virus Res. 2003;59:23\u201361.","journal-title":"Adv Virus Res"},{"key":"1884_CR6","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","volume":"75","author":"WD Crill","year":"2001","unstructured":"Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol. 2001;75:7769\u201373.","journal-title":"J Virol"},{"key":"1884_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-4757-0785-4_12","volume-title":"The Togaviridae and the Flaviviridae","author":"TP Monath","year":"1986","unstructured":"Monath TP. Pathobiology of the flaviviruses. In: Schlesinger S, Schlesinger MJ, editors. The Togaviridae and the Flaviviridae. New York: Plenum Press; 1986. p. 375\u2013440."},{"issue":"29","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","volume":"30","author":"FX Heinz","year":"2012","unstructured":"Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine. 2012;30(29):4301\u20136.","journal-title":"Vaccine"},{"key":"1884_CR9","doi-asserted-by":"publisher","first-page":"13845","DOI":"10.1128\/JVI.02086-14","volume":"88","author":"J Jarmer","year":"2014","unstructured":"Jarmer J, Zlatkovic J, Tsouchnikas G, Vratskikh O, Strau\u00df J, Aberle JH, et al. Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination. J Virol. 2014;88:13845\u201357.","journal-title":"J Virol"},{"key":"1884_CR10","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1128\/JVI.75.8.4002-4007.2001","volume":"75","author":"S Bhardwaj","year":"2001","unstructured":"Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol. 2001;75:4002\u20137.","journal-title":"J Virol"},{"issue":"6","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","volume":"38","author":"JH Ch\u00e1vez","year":"2010","unstructured":"Ch\u00e1vez JH, Silva JR, Amarilla AA, Moraes Figueiredo LT. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Biologicals. 2010;38(6):613\u20138.","journal-title":"Biologicals"},{"key":"1884_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/vbz.2013.1407","volume":"14","author":"L Mathengtheng","year":"2014","unstructured":"Mathengtheng L, Burt FJ. Use of envelope domain III protein for detection and differentiation of flaviviruses in the Free State Province, South Africa. Vector Borne Zoonotic Dis. 2014;14:261\u201371.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"1884_CR13","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1128\/JVI.01886-10","volume":"85","author":"J Zlatkovic","year":"2011","unstructured":"Zlatkovic J, Stiasny K, Heinz FX. Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice. J Virol. 2011;85:1994\u20132003.","journal-title":"J Virol"},{"key":"1884_CR14","doi-asserted-by":"publisher","first-page":"e1645","DOI":"10.1371\/journal.pntd.0001645","volume":"6","author":"CY Chiang","year":"2012","unstructured":"Chiang CY, Huang MH, Hsieh CH, Chen MY, Liu HH, Tsai JP, et al. Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses. PLoS Negl Trop Dis. 2012;6:e1645.","journal-title":"PLoS Negl Trop Dis"},{"key":"1884_CR15","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","volume":"178","author":"JH Chu","year":"2007","unstructured":"Chu JH, Chiang CC, Ng ML. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J Immunol. 2007;178:2699\u2013705.","journal-title":"J Immunol"},{"key":"1884_CR16","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","volume":"29","author":"J Alonso-Padilla","year":"2011","unstructured":"Alonso-Padilla J, de Oya NJ, Bl\u00e1zquez AB, Escribano-Romero E, Escribano JM, Saiz JC. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease. Vaccine. 2011;29:1830\u20135.","journal-title":"Vaccine"},{"key":"1884_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/bioinformatics\/btm076","volume":"23","author":"JS Papadopoulos","year":"2007","unstructured":"Papadopoulos JS, Agarwala R. COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics. 2007;23:1073\u20139.","journal-title":"Bioinformatics"},{"issue":"Suppl 2","key":"1884_CR18","first-page":"43","volume":"65","author":"AB Tkachuk","year":"2014","unstructured":"Tkachuk AB, Lunin VG, Karyagina AS, Gintsburg AL. Problems and prospects of development of the subunit TB vaccine. JAIDS. 2014;65 Suppl 2:43.","journal-title":"JAIDS"},{"key":"1884_CR19","unstructured":"Lyashchuk AM, Aksenova EI, Ershova AS, Grunina TM, Bartov MS, Savina DM, et al. Method for obtaining immunogenic composition based on three hybrid envelope proteins of tick-borne encephalitis virus, that determine the Siberian (DBD2-D3S), European (DBD2-D3E) and Far Eastern (DBD2-D3D) TBEV subtypes; rDBD2-D3S, pDBD2-D3E and rDBD2-D3D recombinant plasmids; Escherichia coli M15 [pREP4] strains, containing recombinant plasmids; chimeric proteins and their application. Priority date 09.10.2014. Patent \u2116 2560588."},{"key":"1884_CR20","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jmv.21587","volume":"81","author":"NS Pripuzova","year":"2009","unstructured":"Pripuzova NS, Tereshkina NV, Gmyl LV, Dzhivanyan TI, Rumyantsev AA, Liu R, et al. Safety evaluation of chimeric Langat\/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis. J Med Virol. 2009;81:1777\u201385.","journal-title":"J Med Virol"},{"issue":"4","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"e61094","DOI":"10.1371\/journal.pone.0061094","volume":"8","author":"NS Pripuzova","year":"2013","unstructured":"Pripuzova NS, Gmyl LV, Romanova LI, Tereshkina NV, Rogova YV, Terekhina LL, Kozlovskaya LI, Vorovitch MF, Grishina KG, Timofeev AV, Karganova GG. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy. PLoS ONE. 2013;8(4):e61094.","journal-title":"PLoS ONE"},{"key":"1884_CR22","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1016\/0040-4039(91)80672-S","volume":"32","author":"H Vu","year":"1991","unstructured":"Vu H, Hirschbein BL. Internucleotide phosphite sulphurization with tetraethylthiuram disulfide. Phosphorothioate oligonucleotide synthesis via phosphoroamidite chemistry. Tetrahedron Lett. 1991;32:3005\u20138.","journal-title":"Tetrahedron Lett"},{"key":"1884_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","volume":"80","author":"M Ecker","year":"1999","unstructured":"Ecker M, Allison SL, Meixner T, Heinz FX. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol. 1999;80:179\u201385.","journal-title":"J Gen Virol"},{"key":"1884_CR24","first-page":"17","volume":"52","author":"LS Karan\u2019","year":"2007","unstructured":"Karan\u2019 LS, Braslavskaia SI, Miazin AE. Development of amplification technology-based methods for tick-borne encephalitis virus detection and genotyping. Vopr Virusol. 2007;52:17\u201322.","journal-title":"Vopr Virusol"},{"key":"1884_CR25","first-page":"12","volume":"46","author":"VI Zlobin","year":"2001","unstructured":"Zlobin VI, Demina TV, Mamaev LV, Butina TV, Belikov SI, Gorin OZ. Analysis of genetic variability of strains of tick-borne encephalitis virus by primary structure of a fragment of the membrane protein E gene. Vopr Virusol. 2001;46:12\u20136.","journal-title":"Vopr Virusol"},{"key":"1884_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med. 2005;11:522\u201330.","journal-title":"Nat Med"},{"key":"1884_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson TC, Fremont DH, Kuhn RJ, Diamond MS. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe. 2008;4:229\u201338.","journal-title":"Cell Host Microbe"},{"key":"1884_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcv.2012.08.024","volume":"55","author":"FX Heinz","year":"2012","unstructured":"Heinz FX, Stiasny K. Flaviviruses and their antigenic structure. J Clin Virol. 2012;55:289\u201395.","journal-title":"J Clin Virol"},{"key":"1884_CR29","first-page":"13","volume":"57","author":"TV Demina","year":"2012","unstructured":"Demina TV, Dzhioev IP, Kozlova IV, Verkhozina MM, Tkachev SE, Doroshchenko EK, et al. Genotypes 4 and 5 of the tick-borne encephalitis virus: features of the genome structure and possible scenario for its formation. Vopr Virusol. 2012;57:13\u20139.","journal-title":"Vopr Virusol"},{"key":"1884_CR30","doi-asserted-by":"publisher","first-page":"e31981","DOI":"10.1371\/journal.pone.0031981","volume":"7","author":"Y Bertrand","year":"2012","unstructured":"Bertrand Y, T\u00f6pel M, Elv\u00e4ng A, Melik W, Johansson M. First dating of a recombination event in mammalian tick-borne flaviviruses. PLoS ONE. 2012;7:e31981.","journal-title":"PLoS ONE"},{"key":"1884_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/erv.09.139","volume":"9","author":"MG Guzman","year":"2010","unstructured":"Guzman MG, Hermida L, Bernardo L, Ramirez R, Guill\u00e9n G. Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines. 2010;9:137\u201347.","journal-title":"Expert Rev Vaccines"},{"key":"1884_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","volume":"392","author":"WM Wahala","year":"2009","unstructured":"Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology. 2009;392:103\u201313.","journal-title":"Virology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1884-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T23:01:46Z","timestamp":1487718106000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1884-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"article-number":"544"}}